Feasibility of a Cardiac Rehabilitation Program for CTO Patients Before PCI Treatment (NCT06610708) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Feasibility of a Cardiac Rehabilitation Program for CTO Patients Before PCI Treatment
Canada70 participantsStarted 2024-10
Plain-language summary
The goal of this clinical trial is to evaluate the feasibility of a cardiac pre-hab program for patients with blocked arteries (CTO) who are referred for PCI treatment. The main questions it aims to answer are:
Can the pre-hab program improve patients\' functional capacity before PCI? Does the pre-hab program impact the need for PCI based on improvements in patients\' health?
Participants will:
Undergo an initial assessment including a physical exam, medication history, quality of life questionnaires, and blood work.
Complete a 6-month cardiac rehabilitation program. Have repeat assessments to evaluate improvements and determine if PCI is still needed.
If PCI is performed, be assessed again one month later for functional capacity improvements.
If PCI is not needed after 6 months, participants will be followed virtually for an additional 5 months.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
ā. The presence of a chronic total occlusion in at least one major coronary artery (diameter ā„ 2.5mm).
ā. Patients who have an indication for percutaneous coronary intervention of a CTO, which includes the presence of:
ā. Angina or anginal-equivalent symptoms and
ā. Ischemia or viability in the CTO territory
ā. Patient aged ā„18 years of age.
Exclusion criteria
ā. Inability or refusal to participate in the study's cardiac rehabilitation program.
ā. Participation in CR program in the last 1 year.
ā. Life expectancy of \< 12 months due to non-cardiovascular comorbidities.
ā. Anatomy deemed unsuitable for CTO PCI.
ā. Severe left main disease (angiographic stenosis ā„50%; fractional flow reserve ā¤0.80; minimal lumen area \<6mm2).